475 related articles for article (PubMed ID: 28838669)
21. Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies.
Candelise N; Schmitz M; Da Silva Correia SM; Arora AS; Villar-Piqué A; Zafar S; Llorens F; Cramm M; Zerr I
Expert Rev Mol Diagn; 2017 Oct; 17(10):897-904. PubMed ID: 28817974
[TBL] [Abstract][Full Text] [Related]
22. Proteomics applications in prion biology and structure.
Moore RA; Faris R; Priola SA
Expert Rev Proteomics; 2015 Apr; 12(2):171-84. PubMed ID: 25795148
[TBL] [Abstract][Full Text] [Related]
23. Prion disease: a deadly disease for protein misfolding.
Chakraborty C; Nandi S; Jana S
Curr Pharm Biotechnol; 2005 Apr; 6(2):167-77. PubMed ID: 15853695
[TBL] [Abstract][Full Text] [Related]
24. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
25. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.
Saborio GP; Permanne B; Soto C
Nature; 2001 Jun; 411(6839):810-3. PubMed ID: 11459061
[TBL] [Abstract][Full Text] [Related]
26. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
[TBL] [Abstract][Full Text] [Related]
27. [Establishment of a protein misfolding cyclic amplification for PrPSc].
Han J; Han L; Shi Q; Shi S; Wang X; Zhang BY; Dong XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):202-4. PubMed ID: 17971920
[TBL] [Abstract][Full Text] [Related]
28. Prion protein misfolding and disease.
Moore RA; Taubner LM; Priola SA
Curr Opin Struct Biol; 2009 Feb; 19(1):14-22. PubMed ID: 19157856
[TBL] [Abstract][Full Text] [Related]
29. Dynamics of the nucleated polymerization model of prion replication.
Rubenstein R; Gray PC; Cleland TJ; Piltch MS; Hlavacek WS; Roberts RM; Ambrosiano J; Kim JI
Biophys Chem; 2007 Feb; 125(2-3):360-7. PubMed ID: 17084016
[TBL] [Abstract][Full Text] [Related]
30. Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology.
Cosseddu GM; Nonno R; Vaccari G; Bucalossi C; Fernandez-Borges N; Di Bari MA; Castilla J; Agrimi U
PLoS Pathog; 2011 Nov; 7(11):e1002370. PubMed ID: 22114554
[TBL] [Abstract][Full Text] [Related]
31. Heparan Sulfate and Heparin Promote Faithful Prion Replication in Vitro by Binding to Normal and Abnormal Prion Proteins in Protein Misfolding Cyclic Amplification.
Imamura M; Tabeta N; Kato N; Matsuura Y; Iwamaru Y; Yokoyama T; Murayama Y
J Biol Chem; 2016 Dec; 291(51):26478-26486. PubMed ID: 27821590
[TBL] [Abstract][Full Text] [Related]
32. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
33. Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteins.
Silva JL; Vieira TC; Gomes MP; Bom AP; Lima LM; Freitas MS; Ishimaru D; Cordeiro Y; Foguel D
Acc Chem Res; 2010 Feb; 43(2):271-9. PubMed ID: 19817406
[TBL] [Abstract][Full Text] [Related]
34. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
35. A new mechanism for transmissible prion diseases.
Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Ostapchenko VG; Budka H; Rohwer RG; Baskakov IV
J Neurosci; 2012 May; 32(21):7345-55. PubMed ID: 22623680
[TBL] [Abstract][Full Text] [Related]
36. Cofactors influence the biological properties of infectious recombinant prions.
Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J
Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186
[TBL] [Abstract][Full Text] [Related]
37. Cavitation during the protein misfolding cyclic amplification (PMCA) method--The trigger for de novo prion generation?
Haigh CL; Drew SC
Biochem Biophys Res Commun; 2015 Jun; 461(3):494-500. PubMed ID: 25892519
[TBL] [Abstract][Full Text] [Related]
38. Possible role for Ca2+ in the pathophysiology of the prion protein?
Peggion C; Bertoli A; Sorgato MC
Biofactors; 2011; 37(3):241-9. PubMed ID: 21698700
[TBL] [Abstract][Full Text] [Related]
39. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
40. Prion protein aggregation and fibrillogenesis in vitro.
Stöhr J
Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
